Rituxem 500 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Rituxem 500 mg Injection

Rituxem 500 mg Injection

Rituxem 500 mg Injection contains rituximab and is a monoclonal antibody medicine used for certain blood cancers and autoimmune conditions. It works by targeting the CD20 protein found on B cells, helping the immune system remove abnormal or overactive B cells. The medicine is given as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to CD20-positive B cells and supports their destruction through immune-mediated mechanisms. Rituxem 500 mg Injection is used in treatment regimens for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and selected autoimmune disorders. The 500 mg presentation is supplied in a 50 mL vial with a concentration of 10 mg/mL. Patients require medical monitoring during treatment, particularly for infusion-related reactions, infections, and changes in blood cell counts.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Concentration 10 mg/mL
Fill Volume 50 mL
Dosage Form Injection
Route of Administration Intravenous infusion

Product Also Known As

Rituxem 500 mg, Rituxem 500 mg Injection, Rituxem 500 mg/50 mL, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL, Rituximab Injection, Anti-CD20 Monoclonal Antibody